Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05929885
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-04-24
Brief Title:
Metronomic Capecitabine Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
Sponsor:
National Cancer Centre Singapore
Organization:
National Cancer Centre Singapore
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-24
First Submit QC Date:
June 29 2023
Study First Post Date:
2023-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-02
Last Update Post Date:
2024-01-03
Last Update Post Date Type:
ACTUAL